Product image of Onbrez Breezhaler (Indacaterol) supplied by GNH India

Onbrez Breezhaler

Active Ingredient:
Indacaterol
Origin:
EU

Onbrez Breezhaler (Indacaterol)

Indacaterol, the active ingredient in Onbrez Breezhaler, is a long‑acting β2‑adrenergic agonist presented as a dry‑powder inhalation formulation for inhalation use. It provides bronchodilation for adults with chronic obstructive pulmonary disease (COPD). GNH India supplies Onbrez Breezhaler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH India supplies Onbrez Breezhaler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Manufacturer / TM Owner

Novartis Europharm Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Onbrez Breezhaler contains indacaterol, a bronchodilator that acts on the airway smooth‑muscle pathway to improve airflow in chronic lung disease.

  • Chronic obstructive pulmonary disease (COPD): provides once‑daily maintenance bronchodilation and reduces exacerbation risk.
  • Stable COPD with dyspnoea: improves exercise tolerance and health‑related quality of life.
  • COPD patients inadequately controlled on short‑acting bronchodilators: offers a long‑acting alternative for symptom control.

How It Works

  • Indacaterol selectively stimulates β2‑adrenergic receptors on airway smooth muscle, activating adenylate cyclase and increasing cyclic AMP levels. The rise in cAMP leads to relaxation of bronchial smooth muscle, producing sustained bronchodilation that improves airflow and reduces airway resistance in the lungs.

Side Effects

Adverse reactions to indacaterol are reported across a range of frequencies.

Common Side Effects

  • Cough
  • Throat irritation
  • Nasopharyngitis
  • Headache
  • Dry mouth
  • Upper respiratory tract infection

Serious or Rare Side Effects

  • Paradoxical bronchospasm
  • Cardiovascular events such as tachycardia or palpitations
  • Severe allergic reactions (anaphylaxis)
  • Hypersensitivity skin reactions
  • Acute COPD exacerbation
  • Pneumonia

Precautions & Warnings

When using Onbrez Breezhaler, consider the following safety measures:

  • Assess patient history: review   
  • Monitor  
  • Counsel  
  • Avoid use  
  • Store at ambient :  

-  

Avoid Interactions

  • Indole      
  • Major  
  •   
  •   
  • t  

Frequently Asked Questions

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Indacaterol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT